Fibromyalgia Treatment Market Trends, Size, Growth Insight, Share, Competitive Analysis, Forecast To 2027

(The Express Wire via Comtex)

The global fibromyalgia treatment market size is expected to reach USD 1,414.4 million by 2027, exhibiting a CAGR of 9.2% during the forecast period. The heavy investments in RandD for the development of innovative drugs in pain management will subsequently boost the market growth, states Fortune Business Insights in a report, titled “Fibromyalgia Treatment Market Size, Share andCOVID-19 Impact Analysis, By Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The market size stood at USD 1,918.1 million in 2019.

Request Sample PDF @

The Report Lists the Key Players in this Market:

  • Pfizer, Inc. (U.S.)
  • Eli Lilly and Company (U.S)
  • Allergan (Ireland)
  • Tonix Pharmaceuticals (U.S)
  • Aptinyx (U.S)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Novartis AG (Switzerland)
  • Sun Pharmaceuticals (India)
  • Astellas Pharma Inc (Japan)
  • Other Prominent Players

The coronavirus incident has caused massive loss and disruption to various industries across the globe. We understand that this health disaster has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling, and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.

We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain during this global pandemic.

The report on the market for fibromyalgia treatment encompasses:

  • Outstanding insights into the market
  • Painstaking scrutiny of the segments
  • Recent developments
  • Important data of key players
  • Leading countries
  • Key drivers and restraints
  • COVID-19 impact

The Fibromyalgia Treatment Market report offers an in-depth analysis of the Fibromyalgia Treatment industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major and emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Fibromyalgia Treatment market concentration, and maturity analysis is elaborated in this report.

Get Customized Report @

The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global Fibromyalgia Treatment Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry.

Market Driver:

Strong Pipeline Products to Augment Growth

The prominent companies are focused on introducing innovative therapies to improve their product portfolio in the market. Potential product launches and approvals by regulatory bodies to treat fibromyalgia can greatly impact the fibromyalgia treatment industry in the forthcoming years. For instance, in January 2021, Eli Lilly and Company developed Galcanezumab, which is currently under phase 4 clinical trial. The drug has been approved for migraine and cluster headache; it is estimated to reach its pivotal clinical end-stage by December 2021 to treat fibromyalgia. Similarly, Teva Pharmaceuticals’ AJOVY is approved in the U.S for migraines and is currently under phase 2 clinical trial to manage fibromyalgia.

Lower Frequency of Patients Availing Treatment to Dampen Fibromyalgia Treatment Market Growth amid COVID-19

The COVID-19 outbreak has negatively impacted the global market across the globe. The surging cases of coronavirus have led to the high proclivity towards coronavirus vaccination in the pharmaceutical industry. Moreover, the lower frequency rate of patients availing treatment for fibromyalgia coupled with underdiagnosed indication, will restrict the market growth amid coronavirus. Besides, the increasing production of COVID-19 medicine and preventative vaccines is expected to disrupt fibromyalgia treatment drugs' supply and demand during the pandemic.

Enquire before buying @

Key questions answered in the report:

  1. What will the market growth rate of Fibromyalgia Treatment Market in 2026?
  2. What are the key factors driving the global Fibromyalgia Treatment Market?
  3. Who are the key manufacturers in Fibromyalgia Treatment Market space?
  4. What are the market opportunities, market risk and market overview of the Fibromyalgia Treatment Global market?
  5. What are sales, revenue, and price analysis of top manufacturers of Fibromyalgia Treatment Global market?
  6. What are sales, revenue, and price analysis by types and applications of Fibromyalgia Treatment Market?
  7. What are sales, revenue, and price analysis by regions of Fibromyalgia Treatment Market?


  • Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Fibromyalgia by key Regions
    • Key Industry Trends
    • Pipeline Analysis
    • Regulatory Scenario
    • Recent Industry Developments Such as Mergers and Acquisitions
    • Impact of COVID-19 on the Market
  • Global Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Drug Class
      • Antidepressants
      • Antiepileptic
      • Muscle Relaxants
      • Others
    • Market Analysis, Insights and Forecast By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast By Country
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East and Africa
  • North America Fibromyalgia Treatment Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis By Drug Class
      • Antidepressants
      • Antiepileptic
      • Muscle Relaxants
      • Others
    • Market Analysis By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis By Country
      • U.S.
        • By Drug Class
          • Antidepressants
          • Antiepileptic
          • Muscle Relaxants
          • Others
      • Canada
        • By Drug Class
          • Antidepressants
          • Antiepileptic
          • Muscle Relaxants
          • Others

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US:+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Fibromyalgia Treatment Market Trends, Size, Growth Insight, Share, Competitive Analysis, Forecast To 2027

comtex tracking